Table 4.
Medication | With consult (n=149), n (%) | Without consult (n=82), n (%) | Total (N=231), n (%) | Chi-square (df) | P value | |
Any medication | 146 (98) | 68 (82.9) | 214 (92.6) | 17.6 (1) | <.001 | |
Any psychotropic medication | 136 (91.3) | 58 (70.7) | 194 (84) | 16.6 (1) | <.001 | |
|
Antipsychotic | 102 (68.5) | 40 (48.8) | 142 (61.5) | 8.7 (1) | .003 |
|
Antidepressanta | 87 (58.4) | 42 (51.2) | 129 (55.8) | 1.1 (1) | .29 |
|
Anxiolyticb | 66 (44.3) | 23 (28.0) | 89 (38.5) | 5.9 (1) | .02 |
|
Anticonvulsantc | 45 (30.2) | 12 (14.6) | 57 (24.7) | 6.9 (1) | .009 |
|
Lithium | 10 (6.7) | 7 (8.5) | 17 (7.4) | 0.3 (1) | .61 |
|
Alpha-2 agonist | 72 (48.3) | 27 (32.9) | 100 (43.3) | 5.1 (1) | .02 |
|
Stimulant and atomoxetine | 30 (20.1) | 14 (17.1) | 44 (19) | 0.3 (1) | .57 |
aSelective serotonin reuptake inhibitors, duloxetine, tricyclics, mirtazapine, and trazodone were included exclusively within the antidepressant category.
bBenzodiazapines, buspirone, hydroxyzine, beta-blockers, and prazosin were included exclusively within the anxiolytic category.
cAnticonvulsant medication use in the absence of a reported seizure history.